|
|
|
|
LEADER |
01631nam a2200253 a 4500 |
008 |
050201s1999||||sp a |||||||||||||spa|| |
020 |
|
|
|a 84-486-0215-3
|
041 |
|
|
|a spa
|
082 |
|
|
|a WB100
|b H322
|
100 |
|
|
|a HARRISON
|
245 |
|
|
|a PRINCIPIOS DE MEDICINA INTERNA
|
250 |
|
|
|a 14a.
|
260 |
|
|
|a MADRID :
|b McGRAW-HILL-INTERAMERICANA,
|c 1999
|
300 |
|
|
|a 1268 p. ;
|b TAB
|
650 |
|
|
|a MEDICINA INTERNA
|
592 |
|
|
|a 1.-SINTOMAS Y SIGNOS IMPORTANTES.-URENCIAS MEDICAS.-DERMATOLOGIA.-NUTRICION.-HEMATOLOGIA Y ONCOLOGIA.-ENFERMEDADES INFECCIOSAS.-ENFERMEDADES CARDIOVASCULARES.-ENFERMEDADES DEL APARATO RESPIRATORIO.-ENFERMEDADES RENALES.-ENFERMEDADES GASTROINTESTINALES.-ALERGIA, INMUNOLOGIA CLINICA Y REUMATOLOGIA.-ENDOCRINOLOGIA Y METABOLISMO.-NEUROLOGIA.-TRASTORNOS PSIQUIATRICOS Y USO DE SUSTANCIAS PSICOACTIVAS.-REACCIONES ADVERSAS A FARMACOS.-VALORES DE LABORATORIO DE IMPORTANCIA CLINICA.
|
991 |
|
|
|a No asignado
|
992 |
|
|
|a 05/09/2011
|
942 |
|
|
|c BK
|
999 |
|
|
|c 58350
|d 58350
|
952 |
|
|
|0 0
|1 0
|4 0
|6 WB_100_000000000000000_H322
|7 0
|8 CG
|9 101261
|a 17
|b 17
|c CG
|d 2012-08-16
|i 17001632
|o WB100 H322
|p 17001632
|r 2012-08-16
|t 1
|w 2012-08-16
|y BK
|x 20020515
|
952 |
|
|
|0 0
|1 0
|4 0
|6 WB_100_000000000000000_H322
|7 0
|8 CG
|9 101262
|a 17
|b 17
|c CG
|d 2012-08-16
|i 17001633
|o WB100 H322
|p 17001633
|r 2012-08-16
|t 2
|w 2012-08-16
|y BK
|x 20020515
|
952 |
|
|
|0 0
|1 0
|4 0
|6 WB_100_000000000000000_H322
|7 0
|8 CG
|9 101263
|a 17
|b 17
|c CG
|d 2012-08-16
|i 17001780
|o WB100 H322
|p 17001780
|r 2012-08-16
|t 3
|w 2012-08-16
|y BK
|x 20020515
|
952 |
|
|
|0 0
|1 0
|4 0
|6 WB_100_000000000000000_H322
|7 0
|8 CG
|9 101264
|a 17
|b 17
|c CG
|d 2012-08-16
|i 17001781
|o WB100 H322
|p 17001781
|r 2012-08-16
|t 4
|w 2012-08-16
|y BK
|x 20020515
|